Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current Assets:    
Cash and cash equivalents $ 6,771,531 $ 17,787,159
Restricted certificate of deposit 400,375 250,375
Short-term investments 4,959,263
Accounts receivable, net 997,400 1,622,434
Inventories 13,960,390 6,666,912
Contract assets 26,712 573,895
Prepaid expenses 5,125,855 5,046,599
Other current assets 584,492 56,410
Total Current Assets 27,866,755 36,963,047
Property and equipment, net 26,275,377 15,167,367
Operating lease right-of-use asset 2,090,859 317,208
Other assets 104,853 155,490
Total Assets 56,337,844 52,603,112
Current Liabilities:    
Accounts payable 5,712,946 324,484
Accrued liabilities 6,474,818 3,142,977
Contract liability 152,000
Operating lease liabilities - current 616,308 410,158
Total Current Liabilities 12,956,072 3,877,619
Warrant liabilities 14,503,449 32,688,342
Operating lease liabilities - long-term 1,629,516 87,214
Notes payable - long-term, net of discount (related party) 29,925,121 15,922,118
Total Liabilities 59,014,158 52,575,293
Commitments and Contingencies
Stockholders’ Equity (Deficit):    
Common stock, $0.0001 par value; 625,000,000 shares authorized, 49,858,194 and 47,250,771 shares issued, respectively, and 49,858,194 and 47,250,771 shares outstanding, respectively 4,986 4,725
Additional paid-in capital 76,567,814 68,128,196
Accumulated deficit (79,249,114) (68,105,102)
Total Stockholders’ Equity (Deficit) (2,676,314) 27,819
Total Liabilities and Stockholders’ Equity (Deficit) $ 56,337,844 $ 52,603,112